2261-PUB: Update on U.S. Federal Government Programs for Diabetes

Abstract

The U.S. Congress passed Public Law 115-80 in November 2017 requiring the Department of Health and Human Services (HHS) to establish a National Clinical Care Commission. The purpose of this Commission is to evaluate and make recommendations to the U.S. Secretary of Health and to the U.S. Congress regarding improvements to the coordination and leveraging of programs within HHS and other federal agencies (e.g., Veterans Administration) that relate to diabetes and its complications. The Commission was launched in October 2018 and now is reviewing the large scope of federal efforts that support clinicians in providing integrated, high-quality care to individuals with diabetes and its complications. These efforts include identifying current activities and gaps in coordination of federal education and awareness around prevention; treatment; use of new and existing technologies; methods for outreach and dissemination of education and awareness materials; and whether there are opportunities for consolidation of inappropriately overlapping or duplicative federal programs related to diabetes and its complications. This session will provide an overview of the current work of the National Clinical Care Commission with examples from some federal agencies, such as the Centers for Medicare and Medicaid Services, the Agency for Health Care Research and Quality, and the Veterans Administration. Disclosure C. Powell: None.